Trial intelligence / Profile preview

Lidocaine patches for pain control in HCC RFA

NCT05732181Completed

Sponsor
National Cheng Kung University Hospital
Start
May 2017
Primary completion
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine 10% oropharyngeal spray in procedural pain (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Pain severity evaluated by visual analog scale at 3 days. Started May 2017; status: completed.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT05732181.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05732181.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call